Langerhans cells (LCs) are specialized antigen-presenting cells that reside
in the epidermis as sentinels of the immune system. LCs constantly monitor
the epidermal microenvironment by taking up antigen and processing it into
fragments that can be recognized by cells of the adaptive immune response.
Because of their unique migratory ability, LCs can transport antigen from
the epidermis to regional lymph nodes, where they can initiate systemic imm
une responses. The mechanisms of LC trafficking thus seem to be of particul
ar relevance for the induction and maintenance of cutaneous immunity. LCs o
r their putative precursors express surface molecules that allow them to ho
me to skin and localize in the epidermis for prolonged periods of time. Tis
sue injury, microbial infection, and other perturbants of epidermal homeost
asis (eg, contact allergens) provide danger signals, leading to a local pro
duction of proinflammatory cytokines that induce LC mobilization to the lym
phoid tissue. At the same time, signals are generated that recruit LC precu
rsors into the skin to maintain the epidermal LC population. Distinct pairs
of chemokines and their receptors control the migration from blood to epid
ermis and from there to the regional lymphatics. In addition, trafficking i
s controlled at the level of cell adhesion, where LCs downregulate some adh
esion molecules to exit the epidermis and upregulate others to migrate acro
ss the extracellular matrix and home to T-cell areas of regional lymphoid t
issue. The improved understanding of mechanisms that regulate LC traffickin
g might offer new opportunities for therapeutic interventions to suppress,
stimulate, or deviate cutaneous immune responses.